Clinical Trial Update: Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and feasibility of combining ranibizumab with proton beam irradiation for choroidal melanoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Choroidal Melanoma | Phase 1 | Status: COMPLETED